The optimal approach to coronary bifurcations: Systematic rather than simplified?

Authors


  • Conflict of interest: Dr. Mehran reports institutional research grant support from Bristol-Myers Squibb/Sanofi-Aventis and The Medicines Company and consulting agreements with Abbott Vascular, AstraZeneca, Regado Biosciences, and OrthoMcNeil.

No abstract is available for this article.

Ancillary